Hubei Xingfa Chemicals Group Future Growth

Future criteria checks 1/6

Hubei Xingfa Chemicals Group is forecast to grow earnings and revenue by 16.8% and 7.6% per annum respectively. EPS is expected to grow by 17.9% per annum. Return on equity is forecast to be 9.9% in 3 years.

Key information

16.8%

Earnings growth rate

17.9%

EPS growth rate

Chemicals earnings growth	38.2%
Revenue growth rate	7.6%
Future return on equity	9.9%
Analyst coverage	Good
Last updated	27 Oct 2024

Recent future growth updates

Recent updates

Hubei Xingfa Chemicals Group (SHSE:600141) Hasn't Managed To Accelerate Its Returns

Jan 08

Does Hubei Xingfa Chemicals Group (SHSE:600141) Have A Healthy Balance Sheet?

Dec 03

Investors Continue Waiting On Sidelines For Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141)

Oct 17

Some Investors May Be Worried About Hubei Xingfa Chemicals Group's (SHSE:600141) Returns On Capital

Sep 09

Market Still Lacking Some Conviction On Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141)

Jul 17

Does Hubei Xingfa Chemicals Group (SHSE:600141) Have A Healthy Balance Sheet?

Jun 11

Hubei Xingfa Chemicals Group (SHSE:600141) Will Want To Turn Around Its Return Trends

May 21

Benign Growth For Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141) Underpins Its Share Price

Apr 05

Earnings and Revenue Growth Forecasts

SHSE:600141 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	33,808	2,528	4,730	5,158	5
12/31/2025	31,739	2,156	4,804	5,541	6
12/31/2024	29,808	1,829	2,933	4,338	6
9/30/2024	28,114	1,740	-325	1,376	N/A
6/30/2024	27,819	1,564	-711	1,483	N/A
3/31/2024	28,422	1,311	-869	1,451	N/A
12/31/2023	28,105	1,379	-979	1,453	N/A
9/30/2023	27,495	1,894	-858	1,604	N/A
6/30/2023	26,702	2,822	978	3,241	N/A
3/31/2023	28,118	4,559	2,443	5,040	N/A
12/31/2022	30,311	5,852	4,520	6,884	N/A
9/30/2022	31,993	6,654	6,837	8,830	N/A
6/30/2022	31,285	6,760	5,617	7,860	N/A
3/31/2022	28,168	5,668	4,535	6,258	N/A
12/31/2021	23,902	4,282	3,827	5,356	N/A
9/30/2021	19,863	2,800	2,574	4,039	N/A
6/30/2021	18,893	1,655	2,115	3,272	N/A
3/31/2021	18,908	953	1,742	2,725	N/A
12/31/2020	18,317	621	1,480	2,405	N/A
9/30/2020	18,812	361	371	830	N/A
6/30/2020	17,872	315	497	993	N/A
3/31/2020	17,592	280	56	985	N/A
12/31/2019	18,039	302	-49	1,036	N/A
9/30/2019	18,000	312	813	2,108	N/A
6/30/2019	17,969	342	518	1,698	N/A
3/31/2019	18,119	378	886	1,842	N/A
12/31/2018	17,855	402	945	1,899	N/A
9/30/2018	18,155	469	941	2,049	N/A
6/30/2018	17,248	393	N/A	2,514	N/A
3/31/2018	16,006	358	N/A	2,070	N/A
12/31/2017	15,761	318	N/A	2,006	N/A
9/30/2017	15,833	264	N/A	1,618	N/A
6/30/2017	15,834	177	N/A	1,337	N/A
3/31/2017	15,373	119	N/A	1,113	N/A
12/31/2016	14,541	102	N/A	1,146	N/A
9/30/2016	12,963	50	N/A	547	N/A
6/30/2016	12,337	60	N/A	513	N/A
3/31/2016	12,552	70	N/A	687	N/A
12/31/2015	12,392	77	N/A	739	N/A
9/30/2015	12,586	122	N/A	953	N/A
6/30/2015	12,388	510	N/A	803	N/A
3/31/2015	11,882	502	N/A	667	N/A
12/31/2014	11,392	494	N/A	665	N/A
9/30/2014	11,149	406	N/A	261	N/A
6/30/2014	10,941	13	N/A	321	N/A
3/31/2014	10,789	1	N/A	369	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600141's forecast earnings growth (16.8% per year) is above the savings rate (2.8%).

Earnings vs Market: 600141's earnings (16.8% per year) are forecast to grow slower than the CN market (25% per year).

High Growth Earnings: 600141's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600141's revenue (7.6% per year) is forecast to grow slower than the CN market (13.3% per year).

High Growth Revenue: 600141's revenue (7.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600141's Return on Equity is forecast to be low in 3 years time (9.9%).

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/01 19:32
End of Day Share Price	2025/01/27 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hubei Xingfa Chemicals Group Co., Ltd. is covered by 25 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Xiaoman Ni	BOCI Research Ltd.
Xiang Zhang	Changjiang Securities Co. LTD.
Ding Leilei	Chasing Securities

Hubei Xingfa Chemicals Group Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Price target increased by 9.9% to CN¥25.86

Consensus EPS estimates fall by 43%

Consensus EPS estimates fall by 20%

Price target decreased by 8.1% to CN¥33.79

Price target decreased by 9.1% to CN¥37.03

Price target decreased by 9.1% to CN¥37.03

Recent updates

Hubei Xingfa Chemicals Group (SHSE:600141) Hasn't Managed To Accelerate Its Returns

Hubei Xingfa Chemicals Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 01, 2025

Does Hubei Xingfa Chemicals Group (SHSE:600141) Have A Healthy Balance Sheet?

Price target increased by 9.9% to CN¥25.86

Third quarter 2024 earnings released: EPS: CN¥0.46 (vs CN¥0.35 in 3Q 2023)

Investors Continue Waiting On Sidelines For Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141)

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024

Investor sentiment improves as stock rises 17%

Some Investors May Be Worried About Hubei Xingfa Chemicals Group's (SHSE:600141) Returns On Capital

Second quarter 2024 earnings released: EPS: CN¥0.39 (vs CN¥0.15 in 2Q 2023)

Market Still Lacking Some Conviction On Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141)

Hubei Xingfa Chemicals Group Co., Ltd. to Report First Half, 2024 Results on Aug 20, 2024

Dividend of CN¥0.60 announced

Does Hubei Xingfa Chemicals Group (SHSE:600141) Have A Healthy Balance Sheet?

Hubei Xingfa Chemicals Group (SHSE:600141) Will Want To Turn Around Its Return Trends

First quarter 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.40 in 1Q 2023)

Benign Growth For Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141) Underpins Its Share Price

New major risk - Financial position

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Investor sentiment improves as stock rises 16%

Hubei Xingfa Chemicals Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 02, 2024

Hubei Xingfa Chemicals' Controlling Shareholder Plans to Raise its Holdings in the Company

Consensus EPS estimates fall by 43%

New major risk - Revenue and earnings growth

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2023 Results on Oct 28, 2023

Consensus EPS estimates fall by 20%

Price target decreased by 8.1% to CN¥33.79

New minor risk - Profit margin trend

New major risk - Revenue and earnings growth

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q2, 2023 Results on Aug 21, 2023

Price target decreased by 9.1% to CN¥37.03

Price target decreased by 9.1% to CN¥37.03

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Price target decreased to CN¥45.75

Third quarter 2022 earnings released: EPS: CN¥1.17 (vs CN¥1.20 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥1.73 (vs CN¥0.70 in 2Q 2021)

Price target increased to CN¥51.33

Investor sentiment deteriorated over the past week

Price target increased to CN¥49.56

Investor sentiment improved over the past week

Price target increased to CN¥45.41

Investor sentiment improved over the past week

Consensus EPS estimates increase by 14%

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Price target increased to CN¥44.89

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥1.10 (vs CN¥0.22 in 3Q 2020)

Investor sentiment deteriorated over the past week

Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141) signed an Equity Purchase Agreement to acquire additional 18.785% minority stake in Hubei Taisheng Chemical Co., Ltd. from ABC Financial Asset Investment Co., Ltd. for approximately CNY 510 million.

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Consensus EPS estimates increase to CN¥1.66

Second quarter 2021 earnings released: EPS CN¥0.70 (vs CN¥0.14 in 2Q 2020)

Consensus forecasts updated

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.32 (vs CN¥0.02 in 1Q 2020)

Consensus forecasts updated

Full year 2020 earnings released: EPS CN¥0.61 (vs CN¥0.33 in FY 2019)

New 90-day high: CN¥14.78

New 90-day high: CN¥13.77

New 90-day high: CN¥12.40

Third quarter earnings released

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2020 Results on Oct 16, 2020

Analysts lower EPS estimates to CN¥0.35

Earnings released